Literature DB >> 11746315

Combining components of quality of life to increase precision and evaluate trade-offs.

T Lumley1, R J Simes, V Gebski, H M Hudson.   

Abstract

Methods for combining measurements on multiple dimensions of quality of life can reduce the dimensionality of the data and increase the precision of estimation. When the dimensions are weighted according to their importance to patients, the resulting estimate is clinically useful and provides a step towards a true utility estimate. We derive two such weighting methods using linear regression on a measure of overall quality of life and demonstrate their usefulness in the analysis of quality of life data from two clinical trials of cancer therapies. Procedures for transforming the quality of life measures into utility measures are demonstrated. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746315     DOI: 10.1002/sim.1035

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  1 in total

1.  Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone.

Authors:  Chee Khoon Lee; Val J Gebski; Alan S Coates; Anne-Sophie Veillard; Vernon Harvey; Martin Hn Tattersall; Michael J Byrne; Brian Brigham; John Forbes; R John Simes
Journal:  Springerplus       Date:  2013-08-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.